| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 740.5K | $19.74M | - | |
| Other | 150.2K | $4.00M | - | |
| Other | 127.6K | $3.40M | - | |
| Other | 120.2K | $3.21M | - | |
| CFO | 86.0K | $2.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | Lock Kenneth A.71 | Chief Commercial Officer | Sell | 1,023 | $16.85 | $17,234.43 | -1.1% | +24.5% | -17.1% | |
| Mar 7, 2022 | Watanabe Todd Franklin65 | President And CEO | Sale+OE | 3,259 | $16.90 | $55,087.50 | -0.2% | +24.5% | -17.1% | |
| Mar 7, 2022 | Turney Patricia A.71 | SVP, Operations | Sell | 1,023 | $16.85 | $17,234.43 | -1.6% | +24.5% | -17.1% | |
| Mar 7, 2022 | Burrows Scott L74 | Chief Financial Officer | Sell | 303 | $16.85 | $5,104.17 | -0.4% | +24.5% | -17.1% | |
| Mar 7, 2022 | Osborne David W76 | Chief Technical Officer | Sell | 856 | $16.85 | $14,419.79 | -0.2% | +24.5% | -17.1% | |
| Mar 1, 2022 | Watanabe Todd Franklin65 | President And CEO | Sell | 2,153 | $17.75 | $38,221.56 | -0.4% | +19.3% | -4.6% | |
| Mar 1, 2022 | Osborne David W76 | Chief Technical Officer | Sell | 775 | $17.75 | $13,758.34 | -0.3% | +19.3% | -4.6% | |
| Mar 1, 2022 | Burrows Scott L74 | Chief Financial Officer | Sell | 420 | $17.75 | $7,456.13 | -1.9% | +19.3% | -4.6% | |
| Mar 1, 2022 | Turney Patricia A.71 | SVP, Operations | Sell | 936 | $17.75 | $16,616.53 | -4.7% | +19.3% | -4.6% | |
| Mar 1, 2022 | Lock Kenneth A.71 | Chief Commercial Officer | Sell | 935 | $17.75 | $16,598.77 | -2.9% | +19.3% | -4.6% |